Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME CAPABILITIES SNV SNV + CNV DNA + Protein Applications Hematology Solid Tumor Genome Editing Products Tapestri Platform Panels
RESOURCES COMPANY About Careers Newsroom Events Blog SUPPORT CONTACT SIGN IN
X

News & Media

Press Releases News View All
news
August 20, 2020
Mission Bio lines up $70M to help focus cancer drugs on the right patients
press
August 20, 2020
New Publication Highlights the Power of the Mission Bio Tapestri Platform to Monitor Therapy Response and Measure Potential Cancer Relapse
news
August 17, 2020
SoftBank lends WeWork $1.1 billion
news
August 17, 2020
Mission Bio raises $70m to develop cancer therapies
news
August 15, 2020
Mission Bio raises $70M to scale single-cell cancer R&D platform
news
August 14, 2020
Financings for Aug. 14, 2020
news
August 14, 2020
Mission Bio added $70 million in a Series C financing led by Novo Growth, an arm of Novo Holdings. The money will go to scale its Tapestri platform, which its customers use to analyze tumors cell by cell.
news
August 14, 2020
Mission Bio closes $70M round
news
August 14, 2020
We want to be everywhere.' Mission Bio raises $70M behind resistance-hunting sequencing platform
news
August 14, 2020
Mission Bio picks up $70 million Series C
SIGN UP FOR PRODUCT AND EVENT UPDATES
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CAPABILITIES
SNV SNV + CNV DNA + Protein
PRODUCTS
Tapestri Platform Panels
APPLICATIONS
Hematology Solid Tumor Genome Editing
COMPANY CAREERS NEWSROOM EVENTS BLOG RESOURCES SUPPORT CONTACT Privacy Policy Terms of Use
REQUEST QUOTE